Wird geladen...
Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo()
OBJECTIVE: Intravesical bacillus Calmette-Guerin (BCG) is the gold standard for high-grade non-muscle-invasive bladder cancer (NMIBC); however, some patients do not respond to initial therapy while others relapse and/or progress. Therefore, combination strategies that can enhance the efficacy and su...
Gespeichert in:
| Veröffentlicht in: | Urol Oncol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215577/ https://ncbi.nlm.nih.gov/pubmed/22717623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2012.05.007 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|